Skip to main content
Erschienen in: World Journal of Urology 12/2020

05.03.2020 | Original Article

Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success

verfasst von: C. Llorente, A. Guijarro, V. Hernández, G. Fernández-Conejo, J. Passas, L. Aguilar, A. Tejido, C. Hernández, M. Moralejo, D. Subirá, C. González-Enguita, A. Husillos, F. Ortiz, M. Sánchez-Chapado, J. Carballido, I. Castillón, E. Mateo, I. Romero, J. Fernández del Álamo, L. Llanes, C. Blázquez, M. Sánchez-Encinas, J. Borrego, M. Téllez, L. Díez, V. M. Carrero, E. Pérez-Fernández, L. Fuentes-Ramirez, S. García Del Valle

Erschienen in: World Journal of Urology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the effect of an Enhanced Recovery After Surgery (ERAS) program on complications and length of stay (LOS) after radical cystectomy (RC) and to assess if the number and type of components of ERAS play a key role on the decrease of surgical morbidity.

Materials and methods

We analyzed the data of 277 patients prospectively recruited in 11 hospitals undergoing RC initially managed according to local practice (Group I) and later within an ERAS program (Group II). Two main outcomes were defined: 90-day complications rate and LOS. As secondary variables we studied 90-day mortality, 30-day readmission and transfusion rate.

Results

Patients in Group II had a higher use of ERAS measures (98.6%) than those in Group I (78.2%) (p < 0.05). Patients in Groups I and II experienced similar complications (70.5% vs. 66%, p = 0.42). LOS was not different between Groups I and II (12.5 and 14 days, respectively, p = 0.59). The risk of having any complication decreases for patients having more than 15 ERAS measures adopted [RR = 0.815; 95% confidence interval (CI) 0.667–0.996; p = 0.045]. Avoidance of transfusion and nasogastric tube, prevention of ileus, early ambulation and a fast uptake of a regular diet are independently associated with the absence of complications.

Conclusions

Complications and LOS after RC were not modified by the introduction of an ERAS program. We hypothesize that at least 15 measures should be applied to maximize the benefit of ERAS
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55(1):164–174CrossRef Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55(1):164–174CrossRef
2.
Zurück zum Zitat Llorente C, Guijarro A, Hernandez V, Fernandez-Conejo G, Perez-Fernandez E, Pocock S (2019) Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain. World J Urol Llorente C, Guijarro A, Hernandez V, Fernandez-Conejo G, Perez-Fernandez E, Pocock S (2019) Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain. World J Urol
3.
Zurück zum Zitat Burkhard FC, Studer UE, Wuethrich PY (2015) Superior functional outcome after radical cystectomy and orthotopic bladder substitution with restrictive intraoperative fluid management: a follow-up study of a randomized clinical trial. J Urol 193(1):173–178CrossRef Burkhard FC, Studer UE, Wuethrich PY (2015) Superior functional outcome after radical cystectomy and orthotopic bladder substitution with restrictive intraoperative fluid management: a follow-up study of a randomized clinical trial. J Urol 193(1):173–178CrossRef
4.
Zurück zum Zitat Gouvas N, Tan E, Windsor A, Xynos E, Tekkis PP (2009) Fast-track vs standard care in colorectal surgery: a meta-analysis update. Int J Colorectal Dis 24(10):1119–1131 Gouvas N, Tan E, Windsor A, Xynos E, Tekkis PP (2009) Fast-track vs standard care in colorectal surgery: a meta-analysis update. Int J Colorectal Dis 24(10):1119–1131
5.
Zurück zum Zitat Sehgal R, Hill A, Deasy J, McNamara DA, Cahill RA (2012) Fast-track for the modern colorectal department. World J Surg 36(10):2473–2480CrossRef Sehgal R, Hill A, Deasy J, McNamara DA, Cahill RA (2012) Fast-track for the modern colorectal department. World J Surg 36(10):2473–2480CrossRef
6.
Zurück zum Zitat Karl A, Buchner A, Becker A, Staehler M, Seitz M, Khoder W et al (2014) A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol 191(2):335–340CrossRef Karl A, Buchner A, Becker A, Staehler M, Seitz M, Khoder W et al (2014) A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol 191(2):335–340CrossRef
7.
Zurück zum Zitat Tyson MD, Chang SS (2016) Enhanced recovery pathways versus standard care after cystectomy: a meta-analysis of the effect on perioperative outcomes. Eur Urol 70(6):995–1003CrossRef Tyson MD, Chang SS (2016) Enhanced recovery pathways versus standard care after cystectomy: a meta-analysis of the effect on perioperative outcomes. Eur Urol 70(6):995–1003CrossRef
8.
Zurück zum Zitat Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702–706CrossRef Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702–706CrossRef
9.
Zurück zum Zitat Studer UE, Burkhard FC, Schumacher M, Kessler TM, Thoeny H, Fleischmann A et al (2006) Twenty years experience with an ileal orthotopic low pressure bladder substitute—lessons to be learned. J Urol 176(1):161–166CrossRef Studer UE, Burkhard FC, Schumacher M, Kessler TM, Thoeny H, Fleischmann A et al (2006) Twenty years experience with an ileal orthotopic low pressure bladder substitute—lessons to be learned. J Urol 176(1):161–166CrossRef
10.
Zurück zum Zitat Nieuwenhuijzen JA, de Vries RR, Bex A, van der Poel HG, Meinhardt W, Antonini N et al (2008) Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 53(4):834–42 (discussion 842–4) Nieuwenhuijzen JA, de Vries RR, Bex A, van der Poel HG, Meinhardt W, Antonini N et al (2008) Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 53(4):834–42 (discussion 842–4)
11.
Zurück zum Zitat Malavaud B, Vaessen C, Mouzin M, Rischmann P, Sarramon J, Schulman C (2001) Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score. Eur Urol 39(1):79–84 Malavaud B, Vaessen C, Mouzin M, Rischmann P, Sarramon J, Schulman C (2001) Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score. Eur Urol 39(1):79–84
12.
Zurück zum Zitat Novara G, De Marco V, Aragona M, Boscolo-Berto R, Cavalleri S, Artibani W et al (2009) Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 182(3):914–921CrossRef Novara G, De Marco V, Aragona M, Boscolo-Berto R, Cavalleri S, Artibani W et al (2009) Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 182(3):914–921CrossRef
13.
Zurück zum Zitat Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PM, Harrison SC (2003) A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 43(3):246–257CrossRef Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PM, Harrison SC (2003) A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 43(3):246–257CrossRef
14.
Zurück zum Zitat Greer NL, Gunnar WP, Dahm P, Lee AE, MacDonald R, Shaukat A et al (2018) Enhanced recovery protocols for adults undergoing colorectal surgery: a systematic review and meta-analysis. Dis Colon Rectum 61(9):1108–1118CrossRef Greer NL, Gunnar WP, Dahm P, Lee AE, MacDonald R, Shaukat A et al (2018) Enhanced recovery protocols for adults undergoing colorectal surgery: a systematic review and meta-analysis. Dis Colon Rectum 61(9):1108–1118CrossRef
15.
Zurück zum Zitat Pang KH, Groves R, Venugopal S, Noon AP, Catto JWF (2017) Prospective implementation of enhanced recovery after surgery protocols to radical cystectomy. Eur Urol S0302–2838(17):30660–30667 Pang KH, Groves R, Venugopal S, Noon AP, Catto JWF (2017) Prospective implementation of enhanced recovery after surgery protocols to radical cystectomy. Eur Urol S0302–2838(17):30660–30667
16.
Zurück zum Zitat Giannarini G, Crestani A, Inferrera A, Rossanese M, Subba E, Novara G et al (2019) Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies. Miner Urol Nefrol 71(4):309–323 Giannarini G, Crestani A, Inferrera A, Rossanese M, Subba E, Novara G et al (2019) Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies. Miner Urol Nefrol 71(4):309–323
17.
Zurück zum Zitat Dunkman WJ, Manning MW, Whittle J, Hunting J, Rampersaud EN, Inman BA et al (2019) Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study. Perioper Med (Lond) 22(8):9CrossRef Dunkman WJ, Manning MW, Whittle J, Hunting J, Rampersaud EN, Inman BA et al (2019) Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study. Perioper Med (Lond) 22(8):9CrossRef
Metadaten
Titel
Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success
verfasst von
C. Llorente
A. Guijarro
V. Hernández
G. Fernández-Conejo
J. Passas
L. Aguilar
A. Tejido
C. Hernández
M. Moralejo
D. Subirá
C. González-Enguita
A. Husillos
F. Ortiz
M. Sánchez-Chapado
J. Carballido
I. Castillón
E. Mateo
I. Romero
J. Fernández del Álamo
L. Llanes
C. Blázquez
M. Sánchez-Encinas
J. Borrego
M. Téllez
L. Díez
V. M. Carrero
E. Pérez-Fernández
L. Fuentes-Ramirez
S. García Del Valle
Publikationsdatum
05.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-020-03132-z

Weitere Artikel der Ausgabe 12/2020

World Journal of Urology 12/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.